Log in
Enquire now
Calimmune

Calimmune

Calimmune is a biotechnology company developing gene and stem cell therapies for treating rare and serious diseases.

OverviewStructured DataIssuesContributors

Contents

calimmune.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Regenerative medicine
Regenerative medicine
Stem cell
Stem cell
Gene therapy
Gene therapy
Healthcare
Healthcare
Genetics
Genetics
Therapeutics
Therapeutics
...
Location
United States
United States
Los Angeles
Los Angeles
California
California
Tucson, Arizona
Tucson, Arizona
King of Prussia, Pennsylvania
King of Prussia, Pennsylvania
B2X
B2B
B2B
CEO
‌
Louis Breton
Founder
David Baltimore
David Baltimore
‌
Louis Breton
Legal Name
Calimmune, Inc.
Legal classification
Corporation
Corporation
Date Incorporated
2006
Number of Employees (Ranges)
1 – 10
Full Address
5151 East Broadway Boulevard Suite 1020 Tucson, AZ 85711 United States
CIK Number
1,643,405
Investors
‌
Translational Accelerator
RA Capital Management
RA Capital Management
Alexandria Venture Investments
Alexandria Venture Investments
Mark Solon
Mark Solon
Founded Date
January 1, 2006
Total Funding Amount (USD)
15,900,000
Latest Funding Round Date
May 2015
Glassdoor ID
990372
Latest Funding Type
Series B
Series B
Patents Assigned (Count)
1
Country
United States
United States

Other attributes

Company Operating Status
Closed
Wikidata ID
Q36875407

Calimmune was founded in 2006 based on gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies).

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform

CSL Behring

https://www.prnewswire.com/news-releases/csl-behring-to-acquire-biotech-company-calimmune-and-its-proprietary-stem-cell-gene-therapy-platform-300510086.html

Web

References

Find more companies like Calimmune

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.